Gene expression in normotopic and heterotopic human bone: Increased level of SP7 mRNA in pathological tissue

Molecular and Cellular Biochemistry

Volumn 318, Issue 1-2, 2008, Pages 81-87

  Chauveau, C ^a   Broux, O ^a   Delecourt, C ^b   Hardouin, P ^a   Jeanfils, J ^a   Devedjian, J C ^a  

^a UNIVERSITÉ DU LITTORAL CÔTE D OPALE   (France)

^b Institut Calot Helio Marin   (France)

Author keywords

Heterotopic ossification; Osteocalcin; Osterix SP7; Real time PCR

Indexed keywords

BETA ACTIN; CALCITRIOL RECEPTOR; COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ADULT; ARTICLE; BONE BIOPSY; CONTROLLED STUDY; CORRELATION FUNCTION; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; GENE FUNCTION; HETEROTOPIC OSSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADULT; BONE AND BONES; CHORISTOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 54949150590     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9859-5     Document Type: Article

References (28)

1. Ippolito E, Formisano R, Caterini R et al (1999) Operative treatment of heterotopic hip ossification in patients with coma after brain injury. Clin Orthop Relat Res 365:130-138. doi: 10.1097/00003086-199908000-00018
2. Shehab D, Elgazzar AH, Collier D (2002) Heterotopic ossification. J Nucl Med 43:346-353
3. Sell S, Gaissmaier C, Fritz J et al (1998) Different behavior of human osteoblast-like cells isolated from normal and heterotopic bone in vitro. Calcif Tissue Int 62:51-59. doi: 10.1007/s002239900394
4. Rigaux P, Benabid N, Darriet D et al (2005) Study of serum factors potentially involved in the pathogenesis of heterotopic bone formation after severe brain injury. Joint Bone Spine 72:146-149. doi: 10.1016/ j.jbspin.2004.05.012
5. Lian JB, Stein GS, Stein JL et al (1998) Osteocalcin gene promoter: unlocking the secrets for regulation of osteoblast growth and differentiation. J Cell Biochem 30-31(suppl):62-72. doi:10.1002/ (SICI)1097-4644(1998)72:30/31+<62::AID-JCB10>3.0.CO;2-S
6. Chauveau C, Devedjian JC, Blary MC et al (2004) Gene expression in human osteoblastic cells from normal and heterotopic ossification. Exp Mol Pathol 76:37-43. doi: 10.1016/j.yexmp. 2003.10.001
7. Lee NK, Sowa H, Hinoi E et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469. doi: 10.1016/ j.cell.2007.05.047
8. Bendall AJ, Abate-Shen C (2000) Roles for Msx and Dlx homeoproteins in vertebrate development. Gene 247:17-31. doi: 10.1016/ S0378-1119(00)00081-0
9. Newberry EP, Lafiti T, Towler DA (1998) Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 37:16360-16368. doi: 10.1021/bi981878u
10. Canalis E (1996) Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447. doi: 10.1210/jc.81.10.3441
11. Meyer T, Carlstedt-Duke J, Starr DB (1997) A weak tata box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 272:30709-30714. doi: 10.1074/jbc.272.49.30709
12. Lian JB, Stein JL, Stein GS et al (2001) Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene. Steroids 66:159-170. doi: 10.1016/ S0039-128X(00)00160-4
13. MacDonald PN, Dowd DR, Nakajima S et al (1993) Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cell Biol 13:5907-5917
14. Sims NA, White CP, Sunn KL et al (1997) Human and murine osteocalcin gene expression: Conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo. Mol Endocrinol 11:1695-1708. doi: 10.1210/me.11.11.1695
15. Ducy P, Zhang R, Geoffroy V et al (1997) Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754. doi: 10.1016/ S0092-8674(00)80257-3
16. Nakashima K, Zhou X, Kunkel G et al (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29. doi: 10.1016/S0092-8674(01)00622-5
17. Gao Y, Jheon A, Nourkeyhani H et al (2004) Molecular cloning, structure, expression, and chromosomal localization of human osterix (SP7) gene. Gene 341:101-110. doi: 10.1016/j.gene.2004.05.026
18. Milona MA, Gough JE, Edgar AJ (2003) Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells. BMC Genomics. Published Online. doi: 1471-2164/4/43
19. Kaback LA, Soung do Y, Naik A et al (2008) Osterix/Sp7 regulates mesenchymal stem cell mediated endochondral ossification. J Cell Physiol 214:173-182. doi: 10.1002/jcp. 21176
20. Tu Q, Valverde P, Li S et al (2007) Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng 13:2431-2440. doi: 10.1089/ ten.2006.0406
21. McCabe LR, Banerjee C, Kundu R et al (1996) Developmental expression and activities of specific Fos and Jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation. Endocrinology 137:4398-4408. doi: 10.1210/en.137.10.4398
22. Demay MB, Gerardi JM, DeLuca HF et al (1990) DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 87:369-373. doi: 10.1073/pnas.87.1.369
23. Paredes R, Arriagada G, Cruzat F et al (2004) The Runx2 transcription factor plays a key role in the 1alpha, 25-dihydroxy vitamin D3 receptor-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells. J Steroid Biochem Mol Biol 89-90:269-271. doi: 10.1016/j.jsbmb.2004.03.076
24. Jääskeläinen T, Ryhänen S, Mahonen A et al (2000) Mechanism of action of superactive vitamin D analogs through regulated receptor degradation. J Cell Biochem 76:548-558. doi:10.1002/ (SICI)1097-4644(20000315)76:4<548::AID-JCB3>3.0.CO;2-0
25. Santiso-Mere D, Sone T, Hilliard GMIV et al (1993) Positive regulation of the vitamin receptor by its cognate ligand in heterologous expression systems. Mol Endocrinol 7:833-839. doi: 10.1210/me.7.7.833
26. Yeung F, Law WK, Yeh CH et al (2002) Regulation of human osteocalcin promoter in hormone-independent human prostate cancer cells. J Biol Chem 277:2468-2476. doi: 10.1074/jbc.M105947200
27. Kurata H, Guillot PV, Chan J et al (2007) Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 13:1513-1523. doi: 10.1089/ ten.2006.0374
28. Zhong N, Garman RA, Squire ME et al (2005) Gene expression patterns in bone after 4 days of hind-limb unloading in two inbred strains of mice. Aviat Space Environ Med 76:530-535